Advancing the technology of septal occlusion

The Carag team members are proud to have been leading contributors to the development of the first generation of atHeart Medical's reSept™ ASD Occluder, the first occluder with a metal-free, low-profile, bioresorbable frame intended for percutaneous occlusion of atrial septal defects (ASD). Their engineering and design expertise was instrumental in bringing this innovation from concept to clinical use.

At Carag, I encountered quality medtech engineering and a rare ability to turn ideas from the drawing board into working medical devices, thanks to an impressive concentration of competence, passion and dedication to problem solving.

Laurent Grandidier, Managing Director, atHeart Medical AG

Carag's prototyping workshop provided outstanding support, enabling us to achieve incredibly fast turnaround times with iteration cycles in just days. Carag's team truly understood the urgency of our requests and responded with efficiency and dedication. We couldn’t be more satisfied with their service!

Kuno Limacher, VP Technology, atHeart Medical AG